title: Azithromycin in the treatment of sexually transmitted disease.
abstract: One hundred and eighty-two patients were enrolled in a randomized third-party blinded study to assess the efficacy and safety of azithromycin in the treatment of sexually transmitted diseases. Three regimens of azithromycin, including a single oral dose, were compared with a standard treatment with doxycycline. The patients were followed for four weeks. Efficacy was evaluated in 168 patients (113 azithromycin, 55 doxycycline). Fourteen patients had negative cultures or did not come for all follow-up visits. Of the 168, 138 were infected with Chlamydia trachomatis, 43 with Neisseria gonorrhoeae, and 45 with Ureaplasma urealyticum. Ninety-six per cent of patients with chlamydial infections and 92% of those with gonorrhoea were cured with azithromycin. Two patients infected with N. gonorrhoeae, four with C. trachomatis and six with U. urealyticum had positive cultures on follow-up visits after receiving azithromycin. Of these 11 patients with positive cultures on follow-up visits, seven (five with U. urealyticum and two with C. trachomatis) violated the protocol by having intercourse with infected individuals during the study. Azithromycin was very well tolerated; one patient complained of mild abdominal pain shortly after receiving the drug, seven patients complained of mild nausea and two patients had mild diarrhoea.
authors.affiliation: Department of Microbiology, University of Iceland, Reykjavik.
authors.forename: O
authors.initials: O
authors.lastname: Steingrimsson
authors.forename: J H
authors.initials: JH
authors.lastname: Olafsson
authors.forename: H
authors.initials: H
authors.lastname: Thorarinsson
authors.forename: R W
authors.initials: RW
authors.lastname: Ryan
authors.forename: R B
authors.initials: RB
authors.lastname: Johnson
authors.forename: R C
authors.initials: RC
authors.lastname: Tilton
mesh_terms: D000293:Adolescent; D000328:Adult; D017963:Azithromycin; D002690:Chlamydia Infections / Q000188:drug therapy; D002692:Chlamydia trachomatis / Q000187:drug effects; D004318:Doxycycline / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009180:Mycoplasmatales Infections / Q000188:drug therapy; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D016032:Randomized Controlled Trials as Topic; D012749:Sexually Transmitted Diseases / Q000188:drug therapy*; D014509:Ureaplasma / Q000187:drug effects
chemical_list: D004917:Erythromycin; D017963:Azithromycin; D004318:Doxycycline